Back to Search Results


Clostridium Difficile Colitis

Author: Larry J. Copeland, MD

Registered users can also download a PDF or listen to a podcast of this Pearl.
Log in now, or create a free account to access bonus Pearls features.

Editor:  Ronald T. Burkman, MD

Clostridium difficile should be suspected as a cause of acute diarrhea in patients with recent surgery or antibiotic use. Acute diarrhea is usually defined as the passage of three or more loose or watery stools in a 24-hour period. C. difficile infection can also be transmitted from person to person and thus in addition to hand hygiene, immediate isolation and contact precautions should be instituted. Good handwashing alone may be insufficient, so gloves should be used as well. Hand sanitizers are not effective. Risk factors for C. diff infection include extremes in age, prolonged hospitalization, and living in a nursing home. Clostridium difficile may frequently be cultured from asymptomatic individuals without diarrhea including hospitalized patients and those in long term care facilities. Other less common infectious causes of diarrhea (e.g. enterotoxigenic Escherichia coli, rotavirus, and others) should also be considered in refractory cases. The etiology of acute diarrhea includes a broad differential diagnosis, including infectious causes, the use of bowel stimulants (e.g. magnesium-containing antacids or proton pump inhibitors), intolerance to a specific dietary component (e.g. lactose or gluten), inflammatory bowel disease, and malabsorption.

Antibiotics commonly used in the perioperative period (e.g. clindamycin, ampicillin, cephalosporins and quinolones) may result in intestinal overgrowth of the anaerobic organism, C. difficile. This organism produces a cytotoxin and an enterotoxin, which cause the diarrhea. Symptoms include watery diarrhea (several times a day), abdominal cramping, and occasionally fever and leukocytosis. In more severe cases pseudomembranous colitis may result, which can rarely progress to a necrotizing colitis, toxic megacolon, and possible subsequent perforation with the need for colectomy. The condition may be fatal.

Patients with suspected C. difficile infections, especially if elderly, should be seen and evaluated for dehydration, shock, and surgical complications. Many of these patients will require admission to hospital for intravenous rehydration and evaluation and correction of electrolyte imbalances. Infection is diagnosed by detecting the toxin in unformed stool specimens using a number of different technologies, or by using nucleic acid amplification testing (NAAT). Endoscopy is usually not necessary to make the diagnosis and barium enema imaging is not recommended because of the risk of perforation.

Many patients will resolve their diarrhea with discontinuation of the offending antibiotic. Initial treatment with anti-diarrhea agents is controversial. The initial treatment of choice is oral vancomycin (125mg four times daily for ten days) or fidaxomicin (200mg twice daily for ten days).  Metronidazole (Flagyl) at dosages of 500 mg tid for 10 days is an alternative, second-line agent. Follow-up stool assays for asymptomatic patients are not recommended as they frequently remain positive for weeks after treatment. Relapses are common (20% or more). Recurrences can be treated with more extended oral vancomycin or fidaxomicin. Patients with one recurrence are at risk for others. Probiotics may be beneficial in recurrent disease as adjuvant therapy. Fecal microbiota transplant may also be useful those patients with severe recurrent disease.

Further Reading:

McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 Mar 19;66(7):987-994. doi: 10.1093/cid/ciy149.

Initial Approval May 2012; Revised July 2018


********** Notice Regarding Use ************

The Foundation for Exxcellence in Women’s Health, Inc (“Foundation”) is committed to accuracy and will review and validate all Pearls on an ongoing basis to reflect current practice.

This document is designed to aid practitioners in providing appropriate obstetric and gynecologic care. Recommendations are derived from major society guidelines and high quality evidence when available, supplemented by the opinion of the author and editorial board when necessary. It should not be construed as dictating an exclusive course of treatment or procedure to be followed.

Variations in practice may be warranted when, in the reasonable judgment of the treating clinician, such course of action is indicated by the condition of the patient, limitations of available resources, or advances in knowledge or technology. The Foundation reviews the articles regularly; however, its publications may not reflect the most recent evidence. While we make every effort to present accurate and reliable information, this publication is provided “as is” without any warranty of accuracy, reliability, or otherwise, either express or implied. The Foundation does not guarantee, warrant, or endorse the products or services of any firm, organization, or person. Neither the Foundation, the ABOG, SASGOG nor their respective officers, directors, members, employees, or agents will be liable for any loss, damage, or claim with respect to any liabilities, including direct, special, indirect, or consequential damages, incurred in connection with this publication or reliance on the information presented.

Copyright 2018 The Foundation for Exxcellence in Women's Health, Inc. All rights reserved.  No re-print, duplication or posting allowed without prior written consent.



Back to Search Results